Cholinergic stimulation prevents the development of autoimmune diabetes: Evidence for the modulation of Th17 effector cells via an IFNgamma-dependent mechanism

by Junu George, Ghada Bashir, Mohammed M Qureshi, Yassir A Mohamed, Jamil Roumanos Azzi, Basel K al-Ramadi, Maria J Fernandez-Cabezudo
Published 2016-10-01

Cholinergic Activation Enhances Resistance to Oral Salmonella Infection by Modulating Innate Immune Defense Mechanisms at the Intestinal Barrier

by Ray M. Al-Barazie, Ghada Hassan Bashir, Mohammed M. Qureshi, Yassir A. Mohamed, Ashraf Al-Sbiei, Saeed Tariq, Wim J. Lammers, Basel K. al-Ramadi, Maria J. Fernandez-Cabezudo
Published 2018-03-01

Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes

by Maria J. Fernández-Cabezudo, Junu A. George, Ghada Bashir, Yassir A. Mohamed, Alreem Al-Mansori, Mohammed M. Qureshi, Dietrich E. Lorke, Georg Petroianu, Basel K. al-Ramadi, Basel K. al-Ramadi
Published 2019-05-01

Response to “Creating Consensus: Revisiting the Emergency Medicine Scholarly Activity Requirement”

by Scott H. Pasichow, Zachary J. Jarou, Dhimitri A. Nikolla, Mohammed M. Qureshi, Michael L. Epter, Bryan G. Kane, Vicken Y. Totten, Chadd K. Kraus, Michael Allswede, Deborah B. Diercks, Nidhi Garg, Louis Ling, Eric N. McDonald, Alex M. Rosenau, Mike Wilk, Alexandria D. Holmes, Adam Hemminger, Marna Rayl Greenberg
Published 2019-02-01